Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
J Dairy Sci ; 100(12): 10418-10431, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29153173

ABSTRACT

Since the mid-1800s, farmers have been housing livestock. What began as a part-time solution for cold winters, stormy days, or injured animals has evolved into the main or only area in which cows spend their adult lives. With this change, farmers, academic researchers, and industry innovators have shaped the farm landscape, literally. Over the last 100 years, changes have been made for productivity, health, milk quality, reproduction, animal well-being, and farm profitability. We review a snapshot of those changes and look ahead to the future of lactating dairy cattle housing. All housing systems are moving toward improved cow comfort. Stalls in tiestall and freestall systems are now designed to accommodate cows based on body size and, in some cases, stage of lactation. Farmers may choose to build a compost bedded or traditional bedded-pack barn to maximize cattle rest or accommodate various breeds or sizes of cows. Looking to the future, external pressure and public perception may push farmers to consider other alternatives to total confinement. Future housing plans may include access to pasture or exercise lots, allowing cows to express their preferences for being outside or inside. Housing that allows natural expression of behavior while maintaining cow cleanliness and health may improve the lives of cows and farmers.


Subject(s)
Cattle , Dairying , Housing, Animal , Animals , Female , Lactation , Physical Conditioning, Animal
2.
N Z Vet J ; 64(2): 82-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26208464

ABSTRACT

AIMS: To assess the efficacy of praziquantel (PZQ) administered to control helminths in captive-reared critically endangered black stilts (Himantopus novaezelandiae) before their release into the wild and determine the effect on their survival shortly after release. METHODS: Of 77 captive black stilts, 37 were treated with PZQ prior to release into the wild in South Canterbury, New Zealand, in August and September 2007. Faecal helminth egg counts (FEC) were measured before and after anthelmintic treatment, and before and after release to the wild using modified faecal flotation and sedimentation methods. In addition, total helminth counts were determined in 11 of the birds that died following release, as well as four captive and 11 other wild stilts. RESULTS: The efficacy of PZQ against trematodes was 92% and against Capillaria spp. was 34%. No trematode or Capillaria spp. eggs were detected in treated birds 1 day after treatment, but FEC increased 3-5 days after treatment. There were no differences in the total helminth counts for trematodes, cestodes or Capillaria spp. in control or treated birds (p>0.2). Survival did not differ between treatment groups in the August or September releases (p>0.4). Of control and treated birds, 11/17 (65%) and 8/14 (57%) survived to 31 days, respectively, in the August release, and 16/20 (80%) and 10/15 (67%) survived to 84 days, respectively, in the September release. CONCLUSION: Overall, the results suggest that PZQ treatment may be an unnecessary cost and the risks of producing anthelmintic resistance, injuring the birds during processing or producing an unnecessary stress response at the time of release could exceed any likely benefits. CLINICAL RELEVANCE: It is recommended that pre-release anthelmintic treatment of black stilts should be used only if indicated by health screening. Any treatment should incorporate annual efficacy testing to monitor the emergence of anthelmintic resistance.


Subject(s)
Anthelmintics/therapeutic use , Bird Diseases/parasitology , Helminthiasis, Animal/drug therapy , Praziquantel/therapeutic use , Animal Husbandry/economics , Animals , Anthelmintics/economics , Bird Diseases/drug therapy , Birds , Feces/parasitology , Parasite Egg Count , Praziquantel/economics
3.
Anim Genet ; 39(4): 363-73, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18557973

ABSTRACT

Retrotransposons encompass a specific class of mobile genetic elements that are widespread across eukaryotic genomes. The impact of the varied types of retrotransposons on these genomes is just beginning to be deciphered. In a step towards understanding their role in litopenaeid shrimp, we have herein identified nine non-LTR retrotransposons, among which several appear to exist outside the standard defined clades. Two Litopenaeus stylirostris elements were discovered through degenerate PCR amplification using previously defined non-LTR degenerate primers, and through primers designed from a RAPD-derived sequence. A third genomic L. stylirostris element was identified using specific priming from an amplification protocol. These three PCR-derived sequences showed conserved domains of the non-LTR reverse transcriptase gene. In silico searching of genome databases and subsequent contig construction yielded six non-LTR retrotransposons (both genomic and expressed) in the Litopenaeus vannamei genome that also exhibited the highly conserved domains found in our PCR-derived sequences. Phylogenetic placement among representatives from all non-LTR clades showed a possibly novel monophyletic group that included five of our nine sequences. This group, which included elements from both L. stylirostris and L. vannamei, appeared most closely related to the highly active RTE clade. Our remaining four sequences placed in the CR1 and I clades of retrotransposons, with one showing strong similarity to ancient Penelope elements. This research describes three newly discovered retrotransposons in the L. stylirostris genome. Phylogenetic analysis clusters these in a monophyletic grouping with retrotransposons previously described from two closely related species, L. vannamei and Penaeus monodon.


Subject(s)
Genome , Penaeidae/genetics , Retroelements , Amino Acid Sequence , Animals , Conserved Sequence , Evolution, Molecular , Expressed Sequence Tags , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , RNA-Directed DNA Polymerase/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Terminal Repeat Sequences
5.
Pediatrics ; 107(5): 1065-9, 2001 May.
Article in English | MEDLINE | ID: mdl-11331687

ABSTRACT

OBJECTIVE: To determine the effect of varying dosing schedules and predictor variables on the seroprotection rates and geometric mean titer levels resulting from the hepatitis B vaccination series among adolescents. METHODS: Adolescents received the hepatitis B vaccination series at varying schedules according to their natural adherence patterns. Data collected included participants' medication use; chronic illness; use of cigarettes, alcohol, and marijuana; age; race/ethnicity; and body mass index. Participants' dates of vaccinations were recorded and titer levels for hepatitis B surface antibody were drawn ~12 and 24 months after study enrollment. The data for 498 participants were analyzed using chi(2) tests, Student t tests, logistic regression models, and analysis of variance. RESULTS: Seroprotection rates among adolescents were not affected by late vaccinations. The only factors affecting the achievement of seroprotection ~12 and 24 months after the first vaccination were body mass index and the number of immunizations received. Increased time between doses 1 and 2 and doses 2 and 3 showed a trend toward correlating with increasing titer levels. CONCLUSIONS: Although adolescents at risk of acquiring hepatitis B should receive the hepatitis B vaccination series in a timely fashion, late doses are not detrimental, and may be beneficial, to achieving high antibody levels against the hepatitis B virus.


Subject(s)
Hepatitis B Antibodies/biosynthesis , Hepatitis B Vaccines/administration & dosage , Hepatitis B Vaccines/immunology , Adolescent , Analysis of Variance , Female , Humans , Immunization Schedule , Logistic Models , Male
6.
Br J Cancer ; 82(1): 74-80, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10638969

ABSTRACT

The Auger electron emitting agent 5-[125I]iodo-2'-deoxyuridine (i.e. [125I]IUdR) holds promise for the treatment of residual glioma after surgery because this thymidine analogue kills only proliferating cells. However, malignant cells which are not synthesizing DNA during exposure to the radiopharmaceutical will be spared. To determine whether tumour incorporation of [125I]IUdR could be enhanced by protracted administration, we used a C6 cell line, growing in the brains of Wistar rats, as a glioma model and compared three methods of intracerebral delivery of [125I]IUdR. Twenty-four hours after administration of drug, autoradiography of brain sections demonstrated nuclear uptake of the radiopharmaceutical in cells throughout tumour while normal brain cells remained free of radioactivity. The [125I]IUdR labelling indices (% +/- s.e.m.) achieved were 6.2 (0.4) by single injection, 22.5 (4.1) using a sustained release polymer implant (poly(lactide-co-glycolide)) and 34.3 (2.0) by mini-osmotic pump. These results emphasize the need for a sustained delivery system as a prerequisite for effective treatment. These findings are also encouraging for the development of a sustained release system for radiolabelled IUdR for use in the treatment of intracranial tumours, particularly in the immediate postoperative setting.


Subject(s)
Brain Neoplasms/radiotherapy , Coated Materials, Biocompatible/administration & dosage , Drug Delivery Systems/methods , Glioma/radiotherapy , Idoxuridine/administration & dosage , Iodine Radioisotopes/administration & dosage , Lactic Acid/administration & dosage , Polyglycolic Acid/administration & dosage , Polymers/administration & dosage , Radiopharmaceuticals/administration & dosage , Animals , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Female , Glioma/metabolism , Glioma/pathology , Idoxuridine/pharmacokinetics , Iodine Radioisotopes/pharmacokinetics , Male , Polylactic Acid-Polyglycolic Acid Copolymer , Radiopharmaceuticals/pharmacokinetics , Rats , Rats, Wistar , Tissue Distribution
7.
Lepr Rev ; 71(4): 511-6, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11201907

ABSTRACT

Delayed presentation is a recognized risk factor for disability in leprosy but is the result of complex interactions between physical, social, economic and psychological factors. The present study is a response to the situation in an outpatient clinic in Nepal where the wide variation in delay in presentation was a cause for concern. A purpose-written questionnaire was used to collect information on 166 consecutive outpatient admissions. The data included demographics, the first symptom of leprosy, first actions, initial help-seeking behaviour, the reasons for finally seeking treatment and experience with professional health services. Initial analysis found a relationship between delay in presentation and age, rural environment, leprosy classification, walking time, housing not shared with another person affected by leprosy, and an inappropriate first action. The relationship with lack of education and total travel time just failed to reach significance. Further analysis identified that for the study population initial lack of awareness of leprosy and an inappropriate first action were the primary contributors to delay. Extensive and effective health education is needed to address this situation.


Subject(s)
Attitude to Health , Leprosy/diagnosis , Leprosy/therapy , Adolescent , Adult , Age Distribution , Aged , Ambulatory Care Facilities , Child , Female , Humans , Male , Middle Aged , Nepal , Patient Participation , Population Surveillance , Risk Assessment , Severity of Illness Index , Sex Distribution , Time Factors
8.
J Biomater Sci Polym Ed ; 10(11): 1063-77, 1999.
Article in English | MEDLINE | ID: mdl-10606026

ABSTRACT

A series of macroporous hydrogels has been synthesized, selected from a range of such materials in which the presence of functional groups has been shown to produce sorbent properties with respect to molecules having clinical significance in the field of liver support. The use of freeze thaw polymerization, together with inverse suspension polymerization in hexane, or in brine, enables macroporous beads ranging in size from 150 to 2000 microm, to be prepared from functional monomers exhibiting a range of chemical functionalities and aqueous solubilities. In order to investigate the behaviour of these rigid porous hydrophilic substrates in haemoperfusion, a rat model was used to explore various aspects of whole blood response. The materials were incorporated into an extracorporeal circuit linking the right carotid artery and left jugular vein of male Sprague-Dawley rats. Erythrocyte, leucocyte and platelet levels were monitored over a 240 min haemoperfusion period. The most significant observation is that, apart from the strongly acidic polyacrylic acid substrate. matrix chemistry has relatively little effect on leucocyte or platelet response. The most important factors appear to be surface area, pore size and surface rugosity, which do produce measurable, but not dramatic differences. This is encouraging for future work, since these variables may be manipulated by polymerization conditions.


Subject(s)
Biocompatible Materials/chemistry , Extracorporeal Circulation/methods , Hemoperfusion/methods , Hydrogel, Polyethylene Glycol Dimethacrylate , Acrylates/chemistry , Adsorption , Animals , Blood Cell Count , Hexanes , Male , Methacrylates/chemistry , Microspheres , Particle Size , Platelet Count , Polymers , Porosity , Rats , Rats, Sprague-Dawley , Sodium Chloride , Solvents
9.
J Adolesc Health ; 25(5): 323-7, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10551662

ABSTRACT

OBJECTIVES: To determine adolescents' completion rates and factors affecting completion time of hepatitis B (HBV) vaccination. METHODS: Prior to vaccination, participants from a hospital-based and school-based adolescent clinic completed questionnaires assessing sociodemographic variables, family/friend experience with HBV and the vaccine, likelihood of completing the vaccinations, HBV and vaccine knowledge, risk behaviors, chronic illness, and access to clinic. Vaccination times were recorded. RESULTS: Twenty-six months after initiation of the study, 72% of 896 eligible participants had completed the vaccination series. The independent predictors of shorter time to completion were: higher estimated mean household income [odds ratio (OR) = 1.15, 95% confidence interval (CI) = 1.06-1.25), white race (OR = 1.27, 95% CI = 1.01-1.58), female gender (OR = 1.58, 95% CI = 1.31-1.92], and not having smoked cigarettes (OR for smoking in the past 30 days = 0.74, 95% CI = 0.60-0.92). Site of care, risk factors for acquiring HBV, disease and vaccine knowledge, and self-reported desire to complete the series were not associated with completion time. CONCLUSIONS: The primary factors associated with completion of immunization may not be amenable to intervention; mandated strategies for immunization may be more likely to result in protection for adolescents.


Subject(s)
Hepatitis B Vaccines/administration & dosage , Hepatitis B/prevention & control , Patient Compliance , Vaccination/psychology , Adolescent , Adolescent Health Services , Adult , Attitude to Health , Boston , Child , Female , Humans , Male , Sex Factors , Social Class , Surveys and Questionnaires , Time Factors
10.
Pediatrics ; 104(1): e11, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10390297

ABSTRACT

OBJECTIVE: The relative risk of psychotropic medication use in women with puerperal psychiatric illness who are breastfeeding has yet to be quantified adequately. Although the emotional and medical benefits of breastfeeding and adverse effects of maternal depression on infant development are well described, how these absolute benefits weigh against the potential effects of psychotropic drug use during lactation to ultimately guide clinical decisions is still unclear. The objective of this report was to evaluate the extent that psychotropic medications were present in the serum of infants breastfed by mothers treated with antidepressants and benzodiazepines. DESIGN: Serum samples were obtained from 35 nursing infants whose mothers were treated with psychotropic medications while breastfeeding. When a detectable concentration of medication was reported, information regarding infant behavior was obtained by maternal report. SETTING: The Perinatal and Reproductive Psychiatry Program at Massachusetts General Hospital serves as a regional consultation center for the treatment of psychiatric disorders during pregnancy and the postpartum period. PATIENTS: Subjects were mothers referred to the Perinatal Psychiatry Program for consultation regarding the relative safety of psychotropic medication use while breastfeeding. PRIMARY OUTCOME MEASURES: Presence of detectable levels of medication in infants whose mothers breastfed while taking psychotropic medications during pregnancy and/or during the puerperium and the well-being (based on maternal report) of infants who had detectable serum concentrations of medication. RESULTS: Seventy-four percent (n = 26) of infants had serum medication concentrations below the laboratory limit of detection (assay sensitivity 5-50 ng/mL). In the remaining 26% of the sample (n = 9), serum concentrations of psychotropic medications and/or active metabolites were detected. In each of these cases, infants had been exposed to the medication during pregnancy. Medications were not detected in infant serum when mothers had taken these agents solely during the postpartum period. No readily apparent difficulties with the infants were reported by mothers. CONCLUSIONS: These data support the low incidence of infant toxicity and adverse effects associated with antidepressant and benzodiazepine use during breastfeeding. These data also suggest that infant serum monitoring is helpful in the assessment of medication exposure in children of mothers who breastfeed while using psychotropic medications. Given the limited accumulated data regarding serum concentrations of psychotropic medications in breastfeeding infants, no single agent seems to be safer than another. Therefore, choice of pharmacologic treatment should be guided by the likelihood that it will result in restoration of maternal psychiatric well-being.


Subject(s)
Antidepressive Agents/blood , Breast Feeding , Tranquilizing Agents/blood , Benzodiazepines/blood , Female , Humans , Infant , Infant Behavior/drug effects , Male , Mental Disorders/drug therapy , Pregnancy , Pregnancy Complications/drug therapy , Pregnancy Trimester, Third , Puerperal Disorders/drug therapy
11.
J Adolesc Health ; 22(6): 439-45, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9627813

ABSTRACT

PURPOSE: To describe adolescents' and young adults' knowledge about their health insurance, and to identify factors associated with correct knowledge of health insurance in this population. METHODS: Data were analyzed from a confidential questionnaire administered to 830 patients at a hospital-based adolescent medicine clinic. The questionnaire contained items pertaining to insurance type, demographics, health status, and health-risk behaviors. Actual health insurance data and information regarding utilization of health services were obtained from the hospital billing data-base. Predictors of health insurance knowledge were determined through bivariate analyses followed by stepwise logistic regression. RESULTS: A total of 50.7% of respondents correctly identified their type of health insurance. Those who correctly identified their insurance had a higher mean age. Only 48.5% of participants who were 11-18 years old could identify their insurance type, versus 53.1% of 19-21-year-olds and 64.7% of 22-24-year-olds (p = 0.02). Sixty-five percent of Medicaid patients and 76.3% of hospital free care patients knew how their medical bills were paid, versus 17.9% of self-pay patients and 47.3% of patients with private insurance (p < 0.01). Greater utilization of health services was associated with increased rates of insurance knowledge among 19-24-year-olds on bivariate analysis; however, this factor was not significant when controlling for other factors. Regression analysis revealed that older age and insurance type other than self-payment were independent predictors of health insurance knowledge in adolescents (11-18 years old), while female gender and insurance type other than self-payment were independent predictors of insurance knowledge in young adults (19-24 years old). CONCLUSIONS: Approximately half of adolescents and young adults do not know how their medical bills are paid. Validation of self-reported insurance data is, therefore, critical both in clinical practice and health services research.


Subject(s)
Health Knowledge, Attitudes, Practice , Insurance Coverage , Insurance, Health , Adolescent , Adolescent Health Services , Adult , Child , Female , Health Care Surveys , Humans , Male , Outpatient Clinics, Hospital , Sex Factors
12.
J Pediatr Adolesc Gynecol ; 10(4): 193-8, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9391901

ABSTRACT

OBJECTIVE: To identify factors associated with the use of various birth control methods among sexually active adolescent girls. DESIGN: A survey distributed as part of a larger study measuring compliance with hepatitis B vaccination. SETTING: A hospital-based and a school-based clinic. MEASURES: Demographic and health behavior data including sexual activity, contraceptive method, substance use, condom use, and history of sexually transmitted diseases (STDs) were collected. Birth control method was confirmed by medical record review. Associations with the outcome variable of birth control method were analyzed using chi square, Kruskal-Wallis analyses of variance, and t-tests, followed by logistic regression analysis. RESULTS: Among sexually experienced girls, 39% (n = 123) reported using oral contraceptive pills (OCPs), 5.4% (n = 17) used Depo-Provera (medroxyprogesterone acetate) or Norplant (levonorgestrel), and 55.6% (n = 175) used no hormonal method. Logistic regression analysis revealed that the factors most significantly associated with the use of hormonal methods were older age (odds ratio [OR] = 1.19; 95% confidence interval [CI], 1.07-1.33), not using a condom at last intercourse (OR = 0.55; CI, 0.34-0.90), and having had a well visit within 1 year (OR = 2.11; CI, 1.12-3.70). OCP users were less likely than Depo-Provera or Norplant users to have used alcohol (p = 0.041), cigarettes (p = 0.002), or marijuana (p = 0.018) in the past 30 days. OCP users were less likely than nonusers of hormonal methods to have smoked cigarettes (p = 0.034) or marijuana (p = 0.052). The school-based clinic had a greater proportion of subjects using long-acting progestins (p < 0.001). CONCLUSIONS: The decreased rate of condom use among those who used hormonal birth control methods and the different rates of health risk behaviors among users of various methods require targeted counseling efforts to decrease pregnancy and STD rates among young women.


Subject(s)
Contraceptives, Oral , Sexual Behavior , Adolescent , Adult , Cannabis , Child , Female , Humans , Levonorgestrel , Logistic Models , Medroxyprogesterone Acetate , Pregnancy , Pregnancy in Adolescence , Risk Factors , Sexually Transmitted Diseases/epidemiology , Smoking , Surveys and Questionnaires
13.
J Pediatr ; 131(2): 314-6, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9290624

ABSTRACT

We tested 869 subjects attending either an urban adolescent medicine clinic or a school-based clinic for antibody to hepatitis C virus. Demographic data indicated a representative study sample, and behaviors associated with hepatitis C virus transmission. One subject (0.1%) was seropositive for antibody to hepatitis C virus, indicating a very low prevalence of hepatitis C virus exposure in adolescents.


Subject(s)
Hepatitis C Antibodies/blood , Urban Health , Adolescent , Adolescent Behavior , Adult , Blood Transfusion/statistics & numerical data , Boston/epidemiology , Child , Environmental Exposure , Female , Health Behavior , Hepatitis B Core Antigens/analysis , Hepatitis C/transmission , Hospitals, Pediatric , Humans , Male , Massachusetts/epidemiology , Prevalence , Risk-Taking , School Health Services , Sexual Behavior , Sexually Transmitted Diseases/epidemiology , Substance Abuse, Intravenous/epidemiology , Urban Health/statistics & numerical data
14.
J Am Osteopath Assoc ; 97(3): 150-2, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9107124

ABSTRACT

To determine the influence of swimming on the incidence of otitis media in children, the authors designed a case control survey involving 32 children, aged 1 to 4 years, who were participating in swimming classes. Thirty control subjects were matched for age, race, and sex. The participants were pooled from the general pediatrics clinic and toddler swimming classes in Nassau County, New York. Parents completed a questionnaire gathering data over a 12-week study period during the winter months. Information was gathered regarding demographics, number of ear infections, history and frequency of swimming during the study period, presence of head submersion, day care center attendance, allergies, chronic medical conditions, otolaryngology consultations, ear surgery, and air travel. Forty-three percent of nonswimmers compared with 19% of swimmers had one or more ear infections during the study period (P < .02). The remaining factors surveyed did not differ significantly between groups. A review of the literature yielded two studies suggesting that swimming may have a beneficial effect on eustachian tube function and may indirectly decrease the occurrence of otitis media. Based on these findings, the authors conclude that there appears to be no basis to the commonly held belief that swimming may induce or exacerbate otitis media. In fact, the converse may be true.


Subject(s)
Otitis Media/prevention & control , Swimming , Case-Control Studies , Child, Preschool , Data Collection , Female , Humans , Incidence , Infant , Male , New York , Otitis Media/epidemiology
15.
Biol Psychiatry ; 39(11): 950-4, 1996 Jun 01.
Article in English | MEDLINE | ID: mdl-9162207

ABSTRACT

Pregnancy has been referred to as a time of well-being for patients with psychiatric disorder. However, this impression is derived primarily from anecdotal reports and retrospective studies, rather than systematic prospective evaluation. In this study, 10 pregnant women with previous histories of panic disorder were evaluated prospectively across pregnancy and the postpartum period using the Structured Clinical Interview for DSM-III-R and the Clinical Global Impression. Information regarding pharmacotherapy received was also recorded. Seven of 10 subjects continued to meet DSM-III-R criteria for panic disorder at all trimester visits. Symptoms persisted for some patients even in the context of treatment with antipanic medications. Most subjects (n = 9) met DSM-III-R criteria at 1-3 months postpartum despite nearly uniform intensification of antipanic treatment. Although some women may experience diminished symptoms of panic during pregnancy, in this sample most continued to experience panic attacks and to require antipanic treatment to control symptoms.


Subject(s)
Obstetric Labor Complications/psychology , Panic Disorder/psychology , Pregnancy Complications/psychology , Adult , Female , Humans , Panic Disorder/drug therapy , Postpartum Period/psychology , Pregnancy , Psychiatric Status Rating Scales
16.
Biol Psychiatry ; 38(12): 814-8, 1995 Dec 15.
Article in English | MEDLINE | ID: mdl-8750040

ABSTRACT

Seven women with histories of puerperal psychosis and four with histories of puerperal major depression were consecutively treated with high-dose oral estrogen immediately following delivery. None of the women had histories of nonpuerperal affective disorder, and all women were affectively well throughout the current pregnancy and at delivery. Despite the high risk for recurrent illness in this population, only one woman developed relapse of postpartum affective disorder. All others remained entirely well and required no treatment with psychotropic medications during the 1 year follow-up period. This low rate of relapse, 9% compared to an expected 35-60% without prophylaxis, suggests that oral estrogen may stem the rapid rate of change in estrogen following delivery, thereby preventing the potential impact on dopaminergic and serotonergic neuroreceptors. It is hypothesized that the rapid rate of change of estrogen after delivery creates an "estrogen withdrawal state." This may be a critical factor in driving acute puerperal affective psychosis and early-onset puerperal major depression.


Subject(s)
Depression, Postpartum/drug therapy , Estrogen Replacement Therapy , Estrogens, Conjugated (USP)/administration & dosage , Estrogens/administration & dosage , Psychotic Disorders/drug therapy , Puerperal Disorders/drug therapy , Administration, Oral , Adult , Depression, Postpartum/diagnosis , Depression, Postpartum/psychology , Dose-Response Relationship, Drug , Drug Administration Schedule , Estrogen Replacement Therapy/psychology , Estrogens/adverse effects , Estrogens, Conjugated (USP)/adverse effects , Female , Follow-Up Studies , Humans , Infusions, Intravenous , Personality Inventory , Pilot Projects , Pregnancy , Psychiatric Status Rating Scales , Psychotic Disorders/diagnosis , Psychotic Disorders/psychology , Puerperal Disorders/diagnosis , Puerperal Disorders/psychology , Recurrence , Risk Factors
17.
Am J Psychiatry ; 152(11): 1641-5, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7485628

ABSTRACT

OBJECTIVE: The postpartum period has typically been considered a time of heightened vulnerability for development of affective disorders, and women with bipolar disorder have consistently demonstrated vulnerability to puerperal worsening of mood. This retrospective study examined the extent to which mood-stabilizing agents provide prophylactic benefit to bipolar women during the postpartum period. METHOD: The clinical course of 27 women meeting the DSM-III-R criteria for bipolar disorder was followed during pregnancy and the postpartum period. Information regarding severity of illness (as measured by number of episodes of mania, depression, or both) was obtained, in addition to data on pharmacotherapy (if any) received before, during, and after pregnancy. The extent to which the prophylactic use of antimanic agents minimized the risk of relapse was explored. RESULTS: Only one of the 14 patients taking prophylactic agents during the acute puerperium relapsed within the first 3 months postpartum, while eight of the 13 who did not receive antimanic drugs showed evidence of recurrent affective instability during those 3 months. A survival analysis indicated that the women receiving prophylactic treatment with mood stabilizers maintained well-being significantly longer than the women who did not receive such treatment. CONCLUSIONS: Women with bipolar disorder appear to benefit from puerperal prophylaxis with mood stabilizers. Consistent with results of earlier studies, postpartum prophylaxis was associated with lower rates of relapse into affective disorders. The findings have implications for the early identification and treatment of subgroups of women at particular risk for puerperal illness.


Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/prevention & control , Depression, Postpartum/prevention & control , Adult , Bipolar Disorder/drug therapy , Female , Humans , Lithium/therapeutic use , Pregnancy , Pregnancy Complications/drug therapy , Recurrence , Retrospective Studies , Risk Factors , Severity of Illness Index , Survival Analysis
18.
Neuron ; 14(2): 241-52, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7857636

ABSTRACT

Transcription control regions of eukaryotic genes contain multiple sequence elements proposed to function independently to regulate transcription. We developed transgenic mice carrying fos-lacZ fusion genes with clustered point mutations in each of several distinct regulatory sequences: the sis-inducible element, the serum response element, the fos AP-1 site, and the calcium/cAMP response element. Analysis of Fos-lacZ expression in the CNS and in cultured cells demonstrated that all of the regulatory elements tested were required in concert for tissue- and stimulus-specific regulation of the c-fos promoter. This implies that the regulation of c-fos expression requires the concerted action of multiple control elements that direct the assembly of an interdependent transcription complex.


Subject(s)
Gene Expression Regulation , Genes, fos , Regulatory Sequences, Nucleic Acid , Animals , Binding Sites , Cloning, Molecular , Embryo, Mammalian , Gene Expression , Glial Fibrillary Acidic Protein/analysis , Kainic Acid , Mice , Mice, Transgenic , Microtubule-Associated Proteins/analysis , Mutagenesis, Site-Directed , Neurons/drug effects , Neurons/metabolism , Neurons/physiology , Point Mutation , Polymerase Chain Reaction , Promoter Regions, Genetic , Seizures/chemically induced , Seizures/physiopathology , Telencephalon/physiology , Transcription Factor AP-1/metabolism , Transcription, Genetic , beta-Galactosidase/biosynthesis
19.
Medicina (B Aires) ; 55(2): 140-4, 1995.
Article in Spanish | MEDLINE | ID: mdl-7565051

ABSTRACT

A 5 year old boy with normal phenotype and normal renal function presented tetany. Hypocalcemia and hyperphosphatemia, with increased serum levels of parathyroid hormone (PTH) were detected in serial measurements. Pseudohypoparathyroidism was diagnosed. This disease presents the biochemical abnormalities of hypoparathyroidism (hypocalcemia, hyperphosphatemia) with peripheral resistance to PTH activity. The patient was treated effectively with calcium and vitamin D supplements. The causes of hypocalcemia related to parathyroid gland activity are reviewed and the physiopathology of pseudohypoparathyroidism is described.


Subject(s)
Pseudohypoparathyroidism/physiopathology , Alkaline Phosphatase/blood , Calcium/blood , Calcium/therapeutic use , Child, Preschool , Humans , Magnesium/blood , Male , Phosphates/blood , Pseudohypoparathyroidism/drug therapy
20.
Medicina [B Aires] ; 55(2): 140-4, 1995.
Article in Spanish | BINACIS | ID: bin-37265

ABSTRACT

A 5 year old boy with normal phenotype and normal renal function presented tetany. Hypocalcemia and hyperphosphatemia, with increased serum levels of parathyroid hormone (PTH) were detected in serial measurements. Pseudohypoparathyroidism was diagnosed. This disease presents the biochemical abnormalities of hypoparathyroidism (hypocalcemia, hyperphosphatemia) with peripheral resistance to PTH activity. The patient was treated effectively with calcium and vitamin D supplements. The causes of hypocalcemia related to parathyroid gland activity are reviewed and the physiopathology of pseudohypoparathyroidism is described.

SELECTION OF CITATIONS
SEARCH DETAIL
...